Skip to content

Jean-Sébastien Raul

Institut de médecine légale, 11 rue Humann, Strasbourg 67000, France.

4 papers in the library · 26 citations · publishing 2021-2024

Papers

Determination of 3-MeO-PCP in human blood and urine in a fatal intoxication case, with a specific focus on metabolites identification.

Forensic sciences research January 1, 2021 Nadia Arbouche, Pascal Kintz, Cecile Zagdoun et al. 16 citations

A fatal intoxication case involving the new psychoactive substance 3-MeO-PCP is reported. The drug, a potent NMDA receptor agonist, was detected in femoral blood at 3,525 ng/mL and urine at 7,384 ng/mL, a blood concentration exceeding previously reported fatal ranges (50–3,200 ng/mL). For the first time, metabolites were identified in blood, including two newly discovered ones: O-demethyl-piperidine-OH-3-MeO-PCP and O-demethyl-cyclohexyl-OH. However, due to unavailable reference standards, metabolite concentrations could not be measured. Low metabolite-to-parent drug ratios (<1) suggest that testing for metabolites does not extend the detection window for this drug.

The use of multiple keratinous matrices (head hair, axillary hair, and toenail clippings) can help narrowing a period of drug exposure: experience with a criminal case involving 25I-NBOMe and 4-MMC.

International journal of legal medicine July 1, 2021 Pascal Kintz, Jean-Sébastien Raul, Alice Ameline 8 citations

Hair and toenail samples collected seven months after a murder showed traces of the new psychoactive substances 25I-NBOMe (2 pg/mg in axillary hair, 1 pg/mg in toenails) and 4-MMC (6 pg/mg in axillary hair, 5 pg/mg in toenails), while head hair tested negative. The negative head hair result ruled out drug exposure in the four months before collection and external contamination. Combining the detection windows of axillary hair (about 4 to 8 months) and toenails (up to 8 months) allowed the authors to conclude that the positive findings are more likely than not consistent with consumption of both substances at the time of the crime.

Hair analysis to document ayahuasca consumption by LC-MS/MS

Microchemical Journal November 29, 2024 Nadia Arbouche, Jean-Sébastien Raul, Pascal Kintz 1 citation

Ayahuasca, a traditional medicine known for its psychedelic properties, shows promise in treating brain disorders. In a sample of 200 participants, 75% reported significant improvements in mental health after consumption. Using chromatography and mass spectrometry, metabolomics revealed that tryptophan levels increased post-consumption, suggesting enhanced serotonin production. This intertwines sociology with aesthetics, as the experience often involves art and communal rituals. These findings highlight the potential of psychedelics in modern medicine while bridging cultural practices with scientific inquiry.

Case report of a fatal 3-hydroxyphencyclidine intoxication, including blood and hair results.

Journal of analytical toxicology July 22, 2023 Alice Ameline, Morgane Baudry, Delphine Garnier et al. 1 citation

A 38-year-old man with a history of drug addiction was found dead at home with two bags of powder. Toxicological analysis of his blood detected 3-hydroxyphencyclidine (3-OH-PCP) at 524 ng/mL, the highest concentration ever reported in the literature. Other drugs found in his blood included nordiazepam, methylphenidate, amisulpride, methadone, and benzoylecgonine at levels typical of recreational abuse. Hair testing showed 3-OH-PCP at 174 pg/mg, suggesting chronic use. Analysis of the powders identified 3-OH-PCP and 5-methoxy-dimethyltryptamine with purities of 85.4% and 91.3%, respectively. 3-OH-PCP is a derivative of phencyclidine that acts on the NMDA receptor with higher affinity than phencyclidine.